Olmecip H 40 Tablet
Images are for reference. Actual packaging may vary.
Hydrochlorothiazide (12.5mg) + Olmesartan Medoxomil (40mg)
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Hydrochlorothiazide inhibits sodium reabsorption in the distal convoluted tubule, leading to increased urine output and decreased blood volume.
Olmesartan Medoxomil blocks angiotensin II receptors, preventing vasoconstriction and lowering blood pressure.
Medical applications
Olmecip H 40 Tablet is a combination antihypertensive medication containing Hydrochlorothiazide 12.5 mg and Olmesartan Medoxomil 40 mg. This formulation is indicated for the treatment of hypertension, helping to lower elevated blood pressure and reduce the risk of cardiovascular events such as stroke and myocardial infarction. Olmesartan Medoxomil, an angiotensin II receptor blocker (ARB), selectively inhibits the binding of angiotensin II to the AT1 receptor, resulting in vasodilation and decreased aldosterone secretion, thereby reducing blood pressure.
Hydrochlorothiazide, a thiazide diuretic, promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, which further aids in lowering blood pressure through volume reduction. The combination of these two agents provides complementary mechanisms of action, enhancing antihypertensive efficacy. Olmecip H 40 is typically administered once daily, with dosage adjustments based on patient response and tolerability.
It is contraindicated in patients with hypersensitivity to either component, anuria, or severe renal impairment. Common adverse effects may include dizziness, hypotension, electrolyte imbalance, and gastrointestinal disturbances. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy to ensure safety and efficacy.
How to use Olmecip H Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Olmecip H 40 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Olmecip H 40 Tablet may cause excessive drowsiness with alcohol.
High Risk
Olmecip H 40 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Olmecip H 40 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Olmecip H 40 Tablet should be used with caution in patients with liver disease. Dose adjustment of Olmecip H 40 Tablet may be needed. Please consult your doctor.
Regular Checkup
Olmecip H 40 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Consult Doctor
Olmecip H 40 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Olmecip H 40 Tablet may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
Regular Checkup
0 reviews for Olmecip H 40 Tablet






